Bioinformatics Boom: How Infectious Diseases & Global Events Shape the 2023-2027 Forecast

Computational biology encompasses a vast range of services, from sequencing – the art of decoding nucleotide orders in samples – to drug discovery, database management, differential gene expression analysis, and many others. These services are invaluable to numerous biotechnology sectors, such as medical, animal, plant, environmental, and forensic biotech. The main applications are in genomics, chemoinformatics, drug design, proteomics, transcriptomics, metabolomics, and more. Primary users range from academic institutions, research centers, healthcare facilities, pharma and biotech giants, and CROs.

The bioinformatics sector witnessed a significant spike, from a valuation of $3.19 billion in 2022 to an anticipated $3.68 billion in 2023, marking a CAGR of 15.19%. It’s essential to note, however, that the ongoing Russia-Ukraine conflict has cast a shadow on the global economic resurgence post-COVID-19. This conflict, laden with economic sanctions and supply chain upheavals, has prompted inflation and impacted global markets. Yet, by 2027, predictions set the bioinformatics market value at a staggering $6.67 billion, boasting a CAGR of 16.05%.

A comprehensive market report series offers an in-depth look at the computational biology arena, detailing statistics, market dynamics, regional demographics, key players, trends, and opportunities. It’s an essential toolkit for anyone keen on mastering the ever-evolving landscape of bioinformatics.

One major trend: technological innovation. In this vein, the Japan-based microbiome specialist, bitBiome Inc. unveiled its Enzyme Discovery service in July 2022. This venture leans heavily on the world’s most extensive microbial genome database (MMGDB), cultivated using bitBiome’s foundational technology, bit-MAP. This tool assists in analyzing both human microbiomes and environmental bacteria from diverse habitats, like oceans or hot springs. Combined with unique bioinformatics and 3D structural modeling, bitBiome is revolutionizing enzyme discovery processes.

Recent mergers and acquisitions also shape the industry landscape. Take, for example, the acquisition of Intomics A/S by the US-based ZS in May 2022. This union combines profound academic know-how, data insights, and technology, enhancing drug discovery efforts. Intomics, hailing from Europe, specializes in bioinformatics and systems biology.

In a regional breakdown, North America emerged as the bioinformatics powerhouse in 2022, with Europe hot on its heels as the fastest-growing player. This research spans several regions, including Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, with countries like Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the US under its purview.

As healthcare embraces the digital age, computational biology stands to benefit immensely. A vivid testament to this is the surge in virtual consultations and the use of electronic health records. The integration of IT in healthcare doesn’t just streamline processes; it enhances patient outcomes. Embracing IT is not a trend; it’s a necessity, and the growth trajectory of bioinformatics services mirrors this sentiment.

In defining market value, it encompasses revenues from services such as single-cell, proteomics, metabolomics, and epigenetics analysis, as well as any related goods sold or included by the service providers.

Prominent names in the bioinformatics domain include Thermo Fisher Scientific Inc., QIAGEN Digital Insights, Illumina Inc., DNAnexus Inc., and many more, each contributing to the sector’s vibrant growth.

Reference:
https://www.researchandmarkets.com/